| Literature DB >> 30110480 |
Lingguang Yang1, Peipei Yin1, Chi-Tang Ho2, Miao Yu1, Liwei Sun1, Yujun Liu1.
Abstract
This study aimed to investigate effects of thermal treatments on major phenolics and their antioxidant contributions in Acer truncatum leaves and flowers (ATL and ATF, respectively). With ultra performance liquid chromatography-diode array detector-quadrupole time-of-flight-mass spectrometer/mass spectrometer, phenolic compositions of ATF were first characterized and compared with those of ATL. An optimized high performance liquid chromatography fingerprint was then established, and 10 major phenolics existing in both ATL and ATF were quantified. Gallic acid derivatives and flavonol-3-O-glycosides were found to be their dominant phenolic constituents, with the former being key constituents which was affected by thermal treatments and further influencing the variations of total phenols. Moreover, the mechanism underlining the changes of phenolics in ATL and ATF by the treatments was characterized as a thermolhydrolysis process. During thermal treatments, polymerized gallotannins were hydrolysed to 1,2,3,4,6-pentakis-O-galloyl-β-d-glucose, ethyl gallate and gallic acid, resulting in more than fivefold and twofold increase of their contents in ATL and ATF, respectively. By contrast, contents and antioxidant contributions of flavonol-3-O-glycosides gradually decreased during the process.\absbreak Overall, this is, to our knowledge, the first report on the effects of thermal treatments on phenolics and their antioxidant contributions in ATL and ATF, and the three gallic acid derivatives with potentially higher bioactivity could be efficiently achieved by thermal treatments.Entities:
Keywords: Acer truncatum leaves and flowers; UPLC-DAD-QTOF-MS/MS analysis; antioxidant contribution; phenolics; thermal treatment
Year: 2018 PMID: 30110480 PMCID: PMC6030319 DOI: 10.1098/rsos.180364
Source DB: PubMed Journal: R Soc Open Sci ISSN: 2054-5703 Impact factor: 2.963
Phenolic compounds identified in ATL and ATF by UPLC-DAD-QTOF-MS/MS analysis. (‘K’ represents Kolniak-Ostek [21]; ‘Di’ represents Díaz-de-Cerio et al. [22]; ‘A’ represents Aguirre-Hernandez et al. [23]; ‘P’ represents Petropoulos et al. [24]; ‘Do’ represents Dorta et al. [25]; ‘ST’ represents those confirmed by the authentic standards while those without a superscript letter was described in Yang et al. [14].)
| peak no. | retention time (min) | [M-H]- ( | error (PPM) | formula | MS/MS fragments ( | identified compoundsa | |
|---|---|---|---|---|---|---|---|
| in ATL | |||||||
| 1 | 2.41 | 258 | 191.0560 | 2.1 | C7H11O6 | 127.0394, 111.0446 | quinic acid |
| 2 | 4.01 | 230, 272 | 343.0659 | −1.7 | C14H15O10 | 169.0134, 125.0234 | theogallin |
| 3 | 4.22 | 272, 227 | 169.0131 | −3.6 | C7H5O5 | 169.0115, 125.0207 | gallic acidST |
| 4 | 6.84 | 327 | 353.0868 | −1.4 | C16H17O9 | 191.0545, 179.0329, 135.0441 | 3- |
| 5 | 7.46 | 326 | 353.0870 | −0.8 | C16H17O9 | 191.0584, 179.0339, 135.0438 | 5- |
| 6 | 10.41 | 272 | 285.0612 | 0.7 | C12H13O8 | 109.0086, 152.9972 | uralenneoside |
| 7 | 11.33 | 309 | 337.0948 | 7.4 | C16H17O8 | 191.0334, 163.0159, 119.0480 | |
| 8 | 12.06 | 310 | 337.0911 | −3.6 | C16H17O8 | 191.0545, 163.0401, 119.0509 | |
| 9b | 14.41 | 327 | 353.0875 | 0.6 | C16H17O9 | 191.0456, 179.0218, 173.0207, 135.0424 | |
| 10b | 14.92 | 327 | 353.0863 | −2.8 | C16H17O9 | 191.0531, 173.0421, 135.0434 | |
| 11 | 18.37 | 284 | 289.0707 | −1.7 | C15H13O6 | 245.0250, 211.9531 | (+)-Catechin |
| 12 | 26.01 | 272, 228 | 197.0450 | 0.0 | C9H9O5 | 124.0160 | ethyl gallateST |
| 13 | 31.74 | 278 | 787.0982 | −1.5 | C34H27O22 | 617.0930, 465.0587, 169.0089 | 1,2,3,6-tetrakis- |
| 14 | 33.24 | 255, 352 | 593.1560 | 9.1 | C27H29O15 | 447.1040, 301.0292 | quercetin-3,7- |
| 15 | 35.03 | 261, 353 | 449.0706 | −3.1 | C20H17O12 | 316.0229, 271.0262 | myricetin-arabinoside/xylopyranoside |
| 16 | 37.64 | 349, 262 | 463.0865 | −2.6 | C21H19O12 | 316.0202, 287.0173 | myricetin-3- |
| 17 | 41.07 | 265, 358 | 463.0912 | 7.6 | C21H19O12 | 300.0266, 271.0263 | quercetin-3- |
| 18 | 44.87 | 262, 357 | 463.0859 | −3.9 | C21H19O12 | 300.0274, 271.0274 | quercetin-3- |
| 19b | 50.02 | 265, 355 | 615.1014 | 4.6 | C28H23O16 | 301.0369, 178.9859, 150.9996 | quercetin-galloylhexosideDi |
| 20b | 53.34 | 265 | 577.1586 | 5.0 | C27H29O14 | 285.0413, 431.0899 | kaempferol-3,7- |
| 21 | 54.19 | 257, 357 | 433.0777 | 1.4 | C20H17O11 | 300.0252, 271.0225 | quercetin-3- |
| 22 | 58.81 | 281 | 939.1146 | 4.5 | C41H31O26 | 769.0890, 617.0790, 169.0135 | pentagalloyl glucose isomer |
| 23 | 60.31 | 280 | 939.1157 | 5.6 | C41H31O26 | 769.0925, 617.0801, 169.0155 | 1,2,3,4,6-pentakis- |
| 24 | 62.25 | 256, 347 | 447.1084 | 0.9 | C25H19O8 | 300.0313, 271.0285 | quercetin 3- |
| 25 | 72.22 | 277 | 1091.1260 | 4.2 | C48H35O30 | 939.1131, 769.0892, 617.0669, 169.0144 | hexagalloyl glucose |
| 26 | 79.55 | 266 | 431.0970 | −1.9 | C21H19O10 | 285.0390, 255.0280 | kaempferol-3- |
| 27b | 82.24 | 266 | 461.1064 | −4.3 | C22H21O10 | 285.0364, 271.0208 | kaempferol-3- |
| in ATF | |||||||
| 1 | 2.41 | 258 | 191.0553 | −1.6 | C7H11O6 | 127.0391, 111.0466 | quinic acid |
| 2b | 2.98 | 274 | 331.0665 | 0.0 | C13H15O10 | 169.0134, 125.0228 | galloyl glucoseDo |
| 3 | 4.22 | 227, 272 | 169.0133 | −2.4 | C7H5O5 | 125.0216 | gallic acidST |
| 4 | 7.44 | 326 | 353.0885 | 3.4 | C16H17O9 | 191.0547, 179.0321, 135.0416 | 5- |
| 5 | 10.47 | 272 | 285.0612 | 0.7 | C12H13O8 | 109.0183, 152.0100 | uralenneoside |
| 6 | 12.06 | 310 | 337.0911 | −3.6 | C16H17O8 | 191.0545, 163.0401, 119.0509 | coumaroylquinic acid |
| 7b | 14.64 | 229 | 595.1291 | −1.3 | C26H27O16 | 462.0802, 299.0132 | quercetin-3- |
| 8 | 26.01 | 228, 273 | 197.0451 | 0.5 | C9H9O5 | 124.0155 | ethyl gallateST |
| 9b | 37.25 | 269, 352 | 609.1490 | 5.6 | C27H29O16 | 465.0681, 300.0294 | quercetin-3- |
| 10 | 37.90 | 349, 262 | 463.0736 | −5.0 | C21H19O12 | 316.0214, 287.0152 | myricetin-3- |
| 11 | 41.33 | 256, 354 | 463.0875 | −0.4 | C21H19O12 | 300.0252, 271.0237 | quercetin-3- |
| 12 | 45.18 | 253, 349 | 463.0916 | 8.4 | C21H19O12 | 300.0291, 271.0265 | quercetin-3- |
| 13b | 50.45 | 264 | 593.1544 | 6.4 | C27H29O15 | 284.0319, 255.0293 | kaempferol-3- |
| 14 | 54.35 | 256, 354 | 433.0768 | −0.7 | C20H17O11 | 300.0264, 271.0249 | quercetin-3- |
| 15b | 55.75 | 266, 348 | 447.0972 | 10.1 | C21H19O11 | 284.0315, 255.0285 | kaempferol-3- |
| 16 | 59.17 | 227, 279 | 939.1108 | 0.4 | C41H31O26 | 769.0939, 617.0818, 169.0163 | pentagalloyl glucose isomer |
| 17 | 60.62 | 227, 279 | 939.1108 | 0.4 | C41H31O26 | 769.0912, 617.0790, 169.0133 | 1,2,3,4,6-pentakis- |
| 18 | 62.49 | 256, 350 | 447.0919 | −1.8 | C21H19O11 | 300.0260, 271.0239 | quercetin 3- |
| 19 | 79.83 | 266 | 431.0976 | −0.5 | C21H19O10 | 284.0309, 255.0305 | kaempferol-3- |
aSuperscript letters in the column ‘identified compounds' represent the references.
bSuperscript letters in the column ‘peak number’ represent the compounds first identified in ATL and ATF.
Figure 1.UPLC-DAD-QTOF-MS spectra data of ATL (green curve) and ATF (yellow curve) extracts (a), together with the 10 mixed standards (b) obtained under the same UPLC conditions. Numbers above the yellow curve correspond to the peak number of phenolics in ATF, while those above the green curve represent the peak number of phenolics in ATL. Numbers 1–10 above the black curve are gallic acid (1), neochlorogenic acid (2), ethyl gallate (3), myricetin-3-O-rhamnoside (4), quercetin-3-O-galactoside (5), quercetin-3-O-glucoside (6), quercetin-3-O-arabinopyranoside (7), 1,2,3,4,6-pentakis-O-galloyl-β-d-glucose (8), quercetin 3-O-rhamnoside (9) and kaempferol-3-O-rhamnoside (10).
Figure 2.HPLC fingerprints of ATL (a) and ATF (b) during the thermal treatment as well as the mix standards of the 10 major phenolics, together with the chemical structure of the 10 major phenolics (c). Chromatographs of ATF, ATL and mixed standards (black curve) were obtained under the same HPLC conditions. ‘L’ and ‘F’ in the Z axials in (a) and (b) represent ATL and ATF, respectively, and the number following ‘L’ and ‘F’ represents the thermal treatment duration. Numbers 1–10 in (a) and (b) correspond to those in (c).
Changes of total phenols (HPLC and Folin–Ciocalteu), together with 10 major phenolics from ATL and ATF for different thermal treatment times. (Results of the contents of 10 major phenolics are expressed as mg individual phenolics 100 g d.w.−1, and different letters in each row mean significant difference (p < 0.05). n.d., not detected.)
| treatment time (h) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| phenolic compounds | 0 | 0.5 | 1 | 2 | 4 | 8 | 10 | 12 | 24 |
| in ATL (peak no.) | |||||||||
| gallic acid (1) | 210.08 ± 1.08i | 224.42 ± 1.19h | 267.46 ± 1.53g | 315.34 ± 1.93f | 410.97 ± 2.74e | 579.05 ± 4.18d | 677.66 ± 5.03c | 1057.79 ± 8.31b | 1325.74 ± 10.63a |
| ethyl gallate (3) | 227.97 ± 1.22h | 289.31 ± 1.72g | 499.64 ± 3.50f | 715.05 ± 5.35e | 1058.25 ± 8.31b | 1159.87 ± 9.19a | 1050.25 ± 8.24b | 960.68 ± 7.47d | 998.87 ± 7.80c |
| 1,2,3,4,6-pentakis- | 470.01 ± 1.87h | 588.24 ± 2.08g | 1011.69 ± 3.89f | 1862.42 ± 8.54e | 3171.77 ± 15.80b | 3357.17 ± 12.83a | 2878.48 ± 14.52c | 1907.9 ± 8.46d | 1037.79 ± 11.93f |
| neochlorogenic acid (2) | 231.17 ± 1.24b | 238.31 ± 1.30a | 232.98 ± 1.26b | 209.02 ± 1.07c | 183.82 ± 0.88d | 171.15 ± 0.79e | 138.6 ± 0.55f | 137.73 ± 0.63f | 137.27 ± 0.72f |
| myricetin-3- | 1289.51 ± 12.31b | 1237.62 ± 9.86c | 1263.37 ± 14.09b | 1329.02 ± 10.66a | 1339.60 ± 10.74a | 1321.89 ± 13.59a | 1053.59 ± 8.27d | 966.12 ± 7.52e | 766.72 ± 5.80f |
| quercetin-3- | 99.54 ± 0.50d | 107.34 ± 0.72c | 93.59 ± 0.39e | 127.39 ± 1.23b | 188.03 ± 1.06a | 130.88 ± 1.37b | 99.22 ± 0.42d | 91.87 ± 0.08e | 84.38 ± 0.36f |
| quercetin-3- | 36.06 ± 0.17c | 35.95 ± 0.04c | 37.2 ± 0.14bc | 38.34 ± 0.25b | 43.21 ± 0.62a | 31.49 ± 0.09d | 24.89 ± 0.28e | n.d. | n.d. |
| quercetin-3- | 76.03 ± 0.30cd | 82.28 ± 0.29a | 77.69 ± 0.13c | 75.05 ± 0.39de | 79.47 ± 0.11b | 73.65 ± 0.62e | 60.84 ± 0.04f | 53.58 ± 0.22g | 34.79 ± 0.05h |
| quercetin 3- | 939.72 ± 4.83f | 981.07 ± 3.98d | 1006.04 ± 3.06c | 966.25 ± 2.92e | 1087.71 ± 3.34a | 1038.63 ± 1.17b | 980.66 ± 2.08d | 864.86 ± 5.62g | 589.53 ± 0.73h |
| kaempferol-3- | 602.19 ± 2.12d | 714.12 ± 3.42b | 807.38 ± 6.18a | 660.16 ± 2.07c | 315.62 ± 5.93e | 205.85 ± 0.56f | 193.77 ± 1.83g | 169.31 ± 0.72h | 124.54 ± 2.46i |
| TPLC* | 4182.29 ± 18.87i | 4498.67 ± 20.14h | 5297.05 ± 24.20f | 6298.04 ± 29.37d | 7878.44 ± 37.33b | 8069.64 ± 38.87a | 7157.96 ± 33.92c | 6209.83 ± 32.34e | 5099.63 ± 29.03g |
| TPFC* | 7579.56 ± 353.52b | 7223.35 ± 323.74b | 7736.01 ± 259.34ab | 7631.25 ± 283.08b | 7814.24 ± 287.06ab | 8333.89 ± 289.75a | 7459.43 ± 277.69b | 7859.64 ± 256.12ab | 7636.14 ± 172.56b |
| TPLC/ TPFC* | 55.18 | 62.28 | 68.47 | 82.53 | 100.82 | 96.83 | 95.96 | 79.01 | 55.18 |
| in ATF (peak no.) | |||||||||
| gallic acid (1) | 340.01 ± 2.25i | 353.5 ± 2.14h | 455.79 ± 3.12g | 519.28 ± 3.66f | 555.68 ± 5.51e | 733.15 ± 3.66d | 901.04 ± 6.95c | 989.27 ± 7.72b | 1665.65 ± 13.59a |
| ethyl gallate (3) | 728.91 ± 5.47e | 905.37 ± 6.99d | 1354.76 ± 10.88c | 1589.85 ± 12.91a | 1564.72 ± 15.32b | 1553.28 ± 8.83b | 1559.66 ± 12.65b | 1580.4 ± 14.83a | 1596.28 ± 12.97a |
| 1,2,3,4,6-pentakis- | 1995.71 ± 15.59i | 2587.77 ± 19.69g | 4528.24 ± 33.12d | 5732.79 ± 51.46a | 5555.93 ± 40.24b | 4643.71 ± 33.92c | 4356.61 ± 35.93e | 4041.69 ± 19.75f | 2448.35 ± 13.72h |
| neochlorogenic acid (2) | 77.82 ± 0.52a | 77.03 ± 0.38a | 76.91 ± 0.71a | 71.69 ± 1.82b | 71.05 ± 0.25b | 66.99 ± 0.53c | 48.56 ± 0.94d | 48.84 ± 0.47d | 31.88 ± 0.15e |
| myricetin-3- | 182.1 ± 0.87b | 189.32 ± 0.92a | 191.92 ± 0.94a | 190.93 ± 0.63a | 182.63 ± 1.28b | 167.86 ± 0.77c | 161.65 ± 0.73d | 164.25 ± 0.82cd | 132.65 ± 0.57f |
| quercetin-3- | 562.14 ± 4.03a | 431.23 ± 2.91c | 419.78 ± 2.81d | 415.46 ± 2.77d | 513.67 ± 3.62b | 346.62 ± 2.19e | 322.87 ± 1.99f | 324.39 ± 2.31f | 264.48 ± 1.50g |
| quercetin-3- | 90.3 ± 0.51b | 89.45 ± 0.28b | 73.74 ± 0.33d | 70.99 ± 0.46f | 70.86 ± 0.58f | 93.71 ± 0.50a | 86.95 ± 0.51c | n.d. | n.d. |
| quercetin-3- | 326.33 ± 0.74c | 346.52 ± 0.81a | 338.27 ± 0.37b | 331.42 ± 1.03c | 301.75 ± 0.66d | 247.74 ± 0.49f | 229.46 ± 0.43g | 222.74 ± 1.18g | 146.72 ± 0.26h |
| quercetin 3- | 329.45 ± 0.75a | 329.01 ± 1.32a | 243.66 ± 0.48b | 246.88 ± 0.49b | 242.54 ± 0.47b | 212.75 ± 0.53c | 206.56 ± 0.82cd | 202.91 ± 0.31d | 167.24 ± 0.38f |
| kaempferol-3- | 731.92 ± 2.12b | 913.25 ± 4.74a | 458.85 ± 1.38c | 67.16 ± 0.32d | 34.22 ± 0.24e | 33.82 ± 0.18e | 32.02 ± 0.60f | 31.72 ± 0.09f | 27.84 ± 0.15g |
| TPLC* | 5364.69 ± 31.15h | 6222.44 ± 36.49g | 8141.91 ± 52.57c | 9236.46 ± 62.00a | 9093.04 ± 63.42b | 8099.63 ± 54.84c | 7905.37 ± 43.79d | 7606.21 ± 52.65e | 6481.09 ± 46.53f |
| TPFC* | 9011.19 ± 198.98cd | 9235.9 ± 288.24ace | 9651.69 ± 314.66ab | 9633.02 ± 134.52a | 9172.41 ± 443.96ad | 9024.89 ± 311.42bde | 8473.4 ± 414.04cdf | 8333.35 ± 286.65f | 8942.1 ± 265.70cd |
| TPLC/ TPFC* | 59.53 | 67.37 | 84.36 | 95.88 | 99.13 | 89.75 | 93.30 | 91.27 | 59.53 |
*‘TPLC’ and ‘TPFC’ mean total phenols determined by HPLC analysis (mg/100 g d.w.) and Folin–Ciocalteu assay (mg GAE/100 g d.w.), respectively; ‘TPLC/ TPFC’ means the proportion of total phenols determined by HPLC analysis over total phenols determined by Folin–Ciocalteu assay (%).
Figure 3.HPLC profiles of ATL and ATF with and without thermal treatment. All chromatographs of ATL (a) and ATF (b) were obtained under the same HPLC condition described. Insets on the upper right corner of (a) and (b) are the enlargement of (a) and (b) between 75 and 100 min, respectively, together with corresponding chromatographs of tannic acid. ‘L0’ and ‘L8’ represents ATL for thermal treatment at 0 and 8 h; ‘F0’ and ‘F2’ represents ATF for thermal treatment at 0 and 2 h.
Figure 4.Antioxidant ability of the 10 major phenolics determined with DPPH (a), ABTS (b) and ORAC (c) assays. Compound numbers 1–10 represent the 10 major phenolics occurring in both ATL and ATF, namely gallic acid (1), neochlorogenic acid (2), ethyl gallate (3), myricetin-3-O-rhamnoside (4), quercetin-3-O-galactoside (5), quercetin-3-O-glucoside (6), quercetin-3-O-arabinopyranoside (7), 1,2,3,4,6-pentakis-O-galloyl-β-d-glucose (8), quercetin 3-O-rhamnoside (9) and kaempferol-3-O-rhamnoside (10). The order of the 10 major phenolics in the figure was based on the rank of their DPPH• scavenging ability with the highest on the left and the lowest on the right. Different letters means there exists significant difference (p < 0.05).
Figure 5.Antioxidant contributions of the 10 major phenolics (colour columns) to the total antioxidant activity (dark lines) in ATL (a,c,e) and ATF (b,d,f). Columns of gallic acid derivatives were coloured with cold (blue), columns of flavonols-3-O-glycosides were coloured with warm (red) and the column of caffeoylquinic acid was coloured in green. Asterisk (*) means there exists significant difference between total antioxidant activity (DPPH, ABTS or ORAC) of unprocessed ATL or ATF and those after thermal treatment.